After her MS diagnosis, Becky was worried her kids would have to care for her, but a stem cell transplant has changed the ...
Everyday Health on MSN
The Effect of Menopause on Multiple Sclerosis
Aging and shifting hormone levels influence how MS changes over time, and the overlap of these factors during midlife can ...
Fenebrutinib shows promise as the first BTK inhibitor for both RMS and PPMS, reducing relapses and slowing disability progression. The FENhance 2 study demonstrated fenebrutinib's efficacy over ...
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune condition in which the body's ...
Findings showed fenebrutinib significantly reduced relapses vs teriflunomide in RMS and was noninferior to ocrelizumab in slowing disability progression in PPMS. Topline data were announced from two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results